These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33598151)

  • 1. Safety evaluation of high-dose intake of casein-derived peptide Met-Lys-Pro in healthy adults: A randomized, double-blind, placebo-controlled trial.
    Yuda N; Tanaka M; Tokushima M; Abe F
    Food Sci Nutr; 2021 Feb; 9(2):662-671. PubMed ID: 33598151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Yuda N; Tanaka M; Yamauchi K; Abe F; Kakiuchi I; Kiyosawa K; Miyasaka M; Sakane N; Nakamura M
    Clin Interv Aging; 2020; 15():743-754. PubMed ID: 32546992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    Matsuzaki Tada A; Hamezah HS; Pahrudin Arrozi A; Abu Bakar ZH; Yanagisawa D; Tooyama I
    J Alzheimers Dis; 2022; 89(3):835-848. PubMed ID: 35964178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of the bovine casein-derived peptide Met-Lys-Pro.
    Yamada A; Sakurai T; Ochi D; Mitsuyama E; Yamauchi K; Abe F
    Food Chem; 2015 Apr; 172():441-6. PubMed ID: 25442576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model.
    Tada AM; Hamezah HS; Yanagisawa D; Morikawa S; Tooyama I
    Front Neurosci; 2020; 14():845. PubMed ID: 32922259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating intestinal absorption of peptide Met-Lys-Pro in casein hydrolysate using Caco-2 and human iPS cell-derived small intestinal epithelial cells.
    Yago T; Yuda N; Tanaka M; Iwao T; Matsunaga T
    Food Res Int; 2024 Oct; 193():114831. PubMed ID: 39160040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel angiotensin I-converting enzyme inhibitory peptide derived from bovine casein.
    Yamada A; Sakurai T; Ochi D; Mitsuyama E; Yamauchi K; Abe F
    Food Chem; 2013 Dec; 141(4):3781-9. PubMed ID: 23993549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled trial evaluating the safety of excessive administration of kaempferol aglycone.
    Akiyama M; Mizokami T; Ito H; Ikeda Y
    Food Sci Nutr; 2023 Sep; 11(9):5427-5437. PubMed ID: 37701215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension.
    Ishida Y; Shibata Y; Fukuhara I; Yano Y; Takehara I; Kaneko K
    Biosci Biotechnol Biochem; 2011; 75(3):427-33. PubMed ID: 21389626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial.
    Nakamura T; Mizutani J; Ohki K; Yamada K; Yamamoto N; Takeshi M; Takazawa K
    Atherosclerosis; 2011 Nov; 219(1):298-303. PubMed ID: 21723554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
    Min LJ; Kobayashi Y; Mogi M; Tsukuda K; Yamada A; Yamauchi K; Abe F; Iwanami J; Xiao JZ; Horiuchi M
    PLoS One; 2017; 12(2):e0171515. PubMed ID: 28158298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
    Tissot AC; Maurer P; Nussberger J; Sabat R; Pfister T; Ignatenko S; Volk HD; Stocker H; Müller P; Jennings GT; Wagner F; Bachmann MF
    Lancet; 2008 Mar; 371(9615):821-7. PubMed ID: 18328929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Wu Z; Hu Y; Xu M; Chen Z; Yang W; Jiang Z; Li M; Jin H; Cui G; Chen P; Wang L; Zhao G; Ding Y; Zhao Y; Yin W
    Lancet Infect Dis; 2021 Jun; 21(6):803-812. PubMed ID: 33548194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension.
    Sano J; Ohki K; Higuchi T; Aihara K; Mizuno S; Kajimoto O; Nakagawa S; Kajimoto Y; Nakamura Y
    J Med Food; 2005; 8(4):423-30. PubMed ID: 16379551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
    Goel G; King T; Daveson AJ; Andrews JM; Krishnarajah J; Krause R; Brown GJE; Fogel R; Barish CF; Epstein R; Kinney TP; Miner PB; Tye-Din JA; Girardin A; Taavela J; Popp A; Sidney J; Mäki M; Goldstein KE; Griffin PH; Wang S; Dzuris JL; Williams LJ; Sette A; Xavier RJ; Sollid LM; Jabri B; Anderson RP
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):479-493. PubMed ID: 28506538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.